The FDA distributed a guidance document for comment purposes only entitled Decentralized Clinical Trials for Drugs, Biological Products, and Devices. Comments can be submitted online until 1 August 2023.
Source: FDA website
The FDA distributed a guidance document for comment purposes only entitled Decentralized Clinical Trials for Drugs, Biological Products, and Devices. Comments can be submitted online until 1 August 2023.
Source: FDA website